Bristol-Myers Squibb (BMY) Announces Receipt of FDA Approval for Opdivo + Yervoy Combo in Certain Metastatic Melanoma
Tweet Send to a Friend
Bristol-Myers Squibb (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) approved Opdivo (nivolumab) in combination with Yervoy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
